Publikasi Scopus 2024 per tanggal 30 September 2024 (820 artikel)

Syahputra G.; Sandhiutami N.M.D.; Hariyatun H.; Hapsari Y.; Gustini N.; Sari M.; Siwi O.G.R.; Putra M.Y.; Fadilah F.; Louisa M.
Syahputra, Gita (57211498930); Sandhiutami, Ni Made Dwi (56692904000); Hariyatun, Hariyatun (57756903800); Hapsari, Yatri (57208135074); Gustini, Nunik (57224173731); Sari, Martha (55980718100); Siwi, Olga Galih Rakha (58071081700); Putra, Masteria Yunovilsa (52264383300); Fadilah, Fadilah (56966708600); Louisa, Melva (41461551400)
57211498930; 56692904000; 57756903800; 57208135074; 57224173731; 55980718100; 58071081700; 52264383300; 56966708600; 41461551400
Purification and characterization of a novel zinc chelating peptides from Holothuria scabra and its ex vivo absorption activity in the small intestine
2024
Journal of Applied Pharmaceutical Science
14
9
235
246
11
0
Doctoral Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Department of Pharmacy, Faculty of Pharmacy, University of Pancasila, Jakarta, Indonesia; Research Center for Genetic Engineering, National Research and Innovation Agency, Cibinong, Indonesia; Department of Medical Chemistry, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Syahputra G., Doctoral Program in Biomedical Science, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Sandhiutami N.M.D., Department of Pharmacy, Faculty of Pharmacy, University of Pancasila, Jakarta, Indonesia; Hariyatun H., Research Center for Genetic Engineering, National Research and Innovation Agency, Cibinong, Indonesia; Hapsari Y., Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Gustini N., Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Sari M., Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Siwi O.G.R., Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Putra M.Y., Research Center for Vaccine and Drug, National Research and Innovation Agency, Cibinong, Indonesia; Fadilah F., Department of Medical Chemistry, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Louisa M., Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Zinc supplements currently marketed in Indonesia are second-generation zinc supplements, which must be improved for the effectiveness caused by their low absorption rate and side effects on the gastrointestinal tract. Third-generation zinc supplements are currently being investigated to improve the effectiveness of the previous generation of supplements. The present study aimed to discover a new alternative source of zinc-chelating peptide (ZCP) from Holothuria scabra. In addition, the research investigates the ZCP characteristics and absorption abilities in an ex vivo evaluation using the everted gut sac model method. The results obtained were six zinc peptides: Asp-Asp-Ala-Phe-Gln-Ala-Phe-Cys; Thr-Asp-Asn-Leu; Leu-Gly-Cys; Pro-Gly-Thr; Ser-Cys; and Pro-Tyr. The characterization showed that the resulting peptides comprised two to eight amino acids with molecular weights between 208 and 915 Da. The highest zinc binding capacity of the peptides was 92.11 mg/100 g at 30 kDa for molecular weight. Fourier-transform infrared spectra indicate that zinc ions (Zn2+) bind to carboxyl groups and interact with nitrogen atoms in amino acids and amides. The scanning electron microscope-energy dispersion spectroscopy results stated that, topographically and morphologically, ZCP has a different surface with peptides with Zn composition in the sample. Furthermore, we evaluated the peptide fractions for ex vivo absorption in the small intestine using the everted gut sac method. We found that zinc-binding peptides transported and enhanced zinc absorption in the duodenum segment at 60 minutes, resulting in a 40% increase in absorption rate. The potency of ZCPs from H. scabra as an alternative to third-generation zinc supplements with higher absorption than previous-generation supplements. © 2024 Gita Syahputra et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Holothuria scabra; intestinal simulation bioassay; organic zinc; peptide hydrolysates; zinc absorption
amino acid; ketamine; unclassified drug; xylazine; zinc chelating peptide; zinc derivative; animal experiment; Article; caloric intake; concentration (parameter); controlled study; drug absorption; drug analysis; drug purification; electrospray; energy dispersive X ray spectroscopy; enzymatic hydrolysis; ex vivo study; Fourier transform infrared spectroscopy; high performance liquid chromatography; Holothuria; Holothuria scabra; inductively coupled plasma mass spectrometry; ionization; liquid chromatography-mass spectrometry; male; molecular weight; nonhuman; rat; scanning electron microscopy; small intestine
National Research and Innovation Agency of the Republic of Indonesia
This research is funded by the National Research and Innovation Agency of the Republic of Indonesia for the Fiscal Year 2024.
Open Science Publishers LLP Inc.
22313354
Article
Q2
258
17213